Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies

被引：0
|
作者：
Linda Harris
Tom O’Connell
Jonathan J. Woolley
Gilbert L’Italien
Tamela Martin
Vladimir Coric
James A. Moren
机构：
[1] Biohaven Pharmaceuticals,
[2] Medicus Economics,undefined
[3] American Headache Society,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Breakthrough; Cost; Dihydroergotamine; Intranasal; Medicaid; Migraine, acute; Migraine, prevention; Monoclonal antibody; Monthly migraine day; Triptan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1141 / 1152
页数：11
相关论文
共 18 条
  • [1] Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
    Harris, Linda
    O'Connell, Tom
    Woolley, Jonathan J.
    L'Italien, Gilbert
    Martin, Tamela
    Coric, Vladimir
    Moren, James A.
    ADVANCES IN THERAPY, 2023, 40 (03) : 1141 - 1152
  • [2] Management costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptans
    Slof, J
    Badia, X
    Láinez, JM
    Galván, J
    Heras, J
    NEUROLOGIA, 2005, 20 (06): : 290 - 298
  • [3] Effects of Switching Acute Treatment on Disability in Migraine Patients Using Triptans
    Serrano, Daniel
    Buse, Dawn C.
    Kori, Shashi H.
    Papapetropoulos, Sypridon
    Cunanan, Cedric M.
    Manack, Aubrey N.
    Reed, Michael L.
    Lipton, Richard B.
    HEADACHE, 2013, 53 (09): : 1415 - 1429
  • [4] SUBCUTANEOUS SUMATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE IN PATIENTS USING DIHYDROERGOTAMINE AS PROPHYLAXIS
    HENRY, P
    DALLENS, H
    HEADACHE, 1993, 33 (08): : 432 - 435
  • [5] Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature
    Weiner, Jennifer R.
    Toy, Edmond L.
    Sacco, Patricia
    Duh, Mei Sheng
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (05) : 751 - 766
  • [6] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
    Kim, Byung-Kun
    Cho, Soo-Jin
    Han, Jeong Hee
    Dell'Agnello, Grazia
    Panni, Tommaso
    Kim, Manho
    Oh, Kyungmi
    Moon, Heui-Soo
    Chu, Min Kyung
    JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494
  • [7] Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: A retrospective database analysis
    Pawaskar, Manjiri D.
    Camacho, Fabian T.
    Anderson, Roger T.
    Cobden, David
    Joshi, Ashish V.
    Balkrishnan, Rajesh
    CLINICAL THERAPEUTICS, 2007, 29 : 1294 - 1305
  • [8] Characteristics, treatment patterns, healthcare resource use, and costs among pediatric patients diagnosed with neurofibromatosis type 1 and plexiform neurofibromas: a retrospective database analysis of a medicaid population
    Yang, Xiaoqin
    Desai, Kaushal
    Agrawal, Neha
    Mirchandani, Kirti
    Chatterjee, Sagnik
    Sarpong, Eric
    Sen, Shuvayu
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (09) : 1555 - 1561
  • [9] Unmet Needs in Japanese Patients Who Report Insufficient Efficacy with Triptans for Acute Treatment of Migraine: Retrospective Analysis of Real-World Data
    Hirata, Koichi
    Ueda, Kaname
    Komori, Mika
    Ye, Wenyu
    Kim, Yongin
    Cotton, Sarah
    Jackson, James
    Treuer, Tamas
    PAIN AND THERAPY, 2021, 10 (01) : 415 - 432
  • [10] Unmet Needs in Japanese Patients Who Report Insufficient Efficacy with Triptans for Acute Treatment of Migraine: Retrospective Analysis of Real-World Data
    Koichi Hirata
    Kaname Ueda
    Mika Komori
    Wenyu Ye
    Yongin Kim
    Sarah Cotton
    James Jackson
    Tamas Treuer
    Pain and Therapy, 2021, 10 : 415 - 432
12